Upper Gastrointestinal Surgery Unit, Division of Surgery, Anaesthesia and Procedural Medicine, Austin Hospital, Heidelberg, VIC, Australia.
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Ann Surg Oncol. 2023 Aug;30(8):4950-4961. doi: 10.1245/s10434-023-13571-8. Epub 2023 May 8.
At a national level, understanding preventable mortality after oesophago-gastric cancer surgery can direct quality-improvement efforts. Accordingly, utilizing the Australian and New Zealand Audit of Surgical Mortality (ANZASM), we aimed to: (1) determine the causes of death following oesophago-gastric cancer resections in Australia, (2) quantify the proportion of potentially preventable deaths, and (3) identify clinical management issues contributing to preventable mortality.
All in-hospital mortalities following oesophago-gastric cancer surgery from 1 January 2010 to 31 December 2020 were analysed using ANZASM data. Potentially preventable and non-preventable cases were compared. Thematic analysis with a data-driven approach was used to classify clinical management issues.
Overall, 636 complications and 123 clinical management issues were identified in 105 mortalities. The most common causes of death were cardio-respiratory in aetiology. Forty-nine (46.7%) deaths were potentially preventable. These cases were characterized by higher rates of sepsis (59.2% vs 33.9%, p = 0.011), multiorgan dysfunction syndrome (40.8% vs 25.0%, p = 0.042), re-operation (63.3% vs 41.1%, p = 0.031) and other complications compared with non-preventable mortality. Potentially preventable mortalities also had more clinical management issues per patient [median (IQR): 2 (1-3) vs 0 (0-1), p < 0.001), which adversely impacted preoperative (30.6% vs 7.1%, p = 0.002), intraoperative (18.4% vs 5.4%, p = 0.037) and postoperative (51.0% vs 17.9%, p < 0.001) care. Thematic analysis highlighted recurrent areas of deficiency with preoperative, intraoperative and postoperative patient management.
Almost 50% of deaths following oesophago-gastric cancer resections were potentially preventable. These were characterized by higher complication rates and clinical management issues. We highlight recurrent themes in patient management to improve future quality of care.
从国家层面上看,了解食管胃交界癌手术后的可预防死亡率可以指导质量改进工作。因此,我们利用澳大利亚和新西兰手术死亡率审核(ANZASM),旨在:(1)确定澳大利亚食管胃交界癌切除术后的死亡原因,(2)量化潜在可预防死亡的比例,以及(3)确定导致可预防死亡率的临床管理问题。
利用 ANZASM 数据,分析 2010 年 1 月 1 日至 2020 年 12 月 31 日期间所有食管胃交界癌手术后的院内死亡率。比较潜在可预防和不可预防的病例。采用主题分析和数据驱动的方法对临床管理问题进行分类。
总共在 105 例死亡病例中发现了 636 例并发症和 123 例临床管理问题。最常见的病因是心肺疾病。49 例(46.7%)死亡病例是潜在可预防的。这些病例的特点是败血症发生率更高(59.2%比 33.9%,p=0.011),多器官功能障碍综合征发生率更高(40.8%比 25.0%,p=0.042),再手术率更高(63.3%比 41.1%,p=0.031),其他并发症发生率也更高,与不可预防的死亡率相比。潜在可预防的死亡率每位患者的临床管理问题也更多[中位数(IQR):2(1-3)比 0(0-1),p<0.001)],这对术前(30.6%比 7.1%,p=0.002)、术中(18.4%比 5.4%,p=0.037)和术后(51.0%比 17.9%,p<0.001)护理产生了不利影响。主题分析突出了术前、术中、术后患者管理中反复出现的缺陷领域。
食管胃交界癌切除术后近 50%的死亡病例是潜在可预防的。这些病例的特点是并发症发生率更高,临床管理问题更多。我们强调了患者管理中反复出现的主题,以提高未来的护理质量。